Daniel Auclair/X
Jun 16, 2025, 17:37
Daniel Auclair Highlights GMMG-CONCEPT Study Presentation by Lisa Leypoldt at EHA 2025
Daniel Auclair, President at Hematocure, LLC, posted on X:
“Dr. Lisa Leypoldt (congrats again on Young Investigator Award!) presenting GMMG-CONCEPT study, the largest prospective trial so far of purely HR NDMM, at EHA2025.
Isa-KRd induction/consolidation and Isa-KR maint. produced high rates MRDneg and was well tolerated.”
More posts featuring EHA 2025 on Hemostasis Today.
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal